Navigation Links
Chairman & CEO of KIWA, Li Wei, Interviewed by Phoenix Satellite TV

BEIJING and CLAREMONT, Calif., Aug. 31 /Xinhua-PRNewswire-FirstCall/ -- KIWA Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announces that Phoenix Satellite will air an exclusive interview of Mr. Li Wei, KIWA's Chairman & CEO.

During the interview, Li Wei introduced KIWA's product development with the China Food Safety Management System process and the China Green Food Association of the Agriculture Ministry.

Phoenix Satellite is broadcast worldwide in Chinese and has one of the highest number of viewers in China and with overseas Chinese speakers. The interview program will show on "Cai Zhi Quan Gong Lue", No. 35, on Phoenix Satellite.

Showing times are:

First broadcast: Sat 08:25-08:55 Sep 1st

Recorded broadcast: Sun 10:30-11:00 Sep 2nd

phoenixtv news channel:

First broadcast: Sat 12:30-13:00 Sep 1st

Recorded broadcast: Sun 20:30-21:00 Sep 1st

Sun 00:30-01:00 Sep 2nd

Phoenix Satellite Television US channel:

First broadcast: Sat 07:30-08:00 Sep 15th

Recorded broadcast: Sat 15:25-15:55 Sep 15th

Phoenix Satellite Television Europe channel:

First broadcast: Sat 07:30-08:00 Sep 15th

Recorded broadcast: Sat 15:25-15:55 Sep 15th

About KIWA Bio-Tech Products Group Corporation

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC ( or visit the Company's website at

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward- looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

For more information, please contact:

KIWA Bio-Tech Products Group Corporation

Yvonne Wang

Phone: +1-626-715-5855


Robert Schechter

Equity Communications

Phone: +1-212-499-6809


SOURCE KIWA Bio-Tech Products Group Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Kyron appoints former AMA chairman to board
2. Third Wave appoints new chairman
3. Cisco Chairman donates $31 million for UW building renovation
4. Bone Care Names New Chairman
5. Cisco Chairman Praises University Research
6. Fully automated DNA purification and efficient multiplex PCR for analysis of microsatellite loci
7. Johnson Controls partners on car satellite linkup
8. Satellite radio can promote your national brand
9. Weather Central launches second satellite
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
Breaking Biology Technology:
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... (NSO), which operates the highest sample volume laboratory in ... Tute Genomics and UNIConnect, leaders in clinical sequencing informatics ... the launch of a project to establish the informatics ... NSO has been contracted by the ...
Breaking Biology News(10 mins):